A breakthrough clinical trial demonstrates that anti-CD19 CAR-T cell immunotherapy can reset the immune system, inducing drug-free remission in patients with severe, treatment-resistant rheumatoid arthritis.
A breakthrough clinical trial demonstrates that anti-CD19 CAR-T cell immunotherapy can reset the immune system, inducing drug-free remission in patients with severe, treatment-resistant rheumatoid arthritis.
